|
Volumn 38, Issue 5, 2002, Pages 615-634
|
Guidelines on endocrine therapy of breast cancerEUSOMA
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA TOCOPHEROL;
ANASTROZOLE;
AROMATASE INHIBITOR;
BELLADONNA ALKALOID;
BIOFLAVONOID;
BUSERELIN;
CLONIDINE;
EXEMESTANE;
GONADORELIN AGONIST;
GOSERELIN;
LETROZOLE;
LEUPRORELIN;
METHYLDOPA;
PHYTOESTROGEN;
SEROTONIN UPTAKE INHIBITOR;
TAMOXIFEN;
TRIPTORELIN;
ACCURACY;
ASSAY;
BLEEDING;
BONE LESION;
BREAST CARCINOMA;
CANCER RISK;
CANCER SURVIVAL;
CHEMOPROPHYLAXIS;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE COURSE;
FOLLOW UP;
HORMONAL THERAPY;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
META ANALYSIS;
MOOD;
POSTMENOPAUSE;
PREGNANCY;
PRIORITY JOURNAL;
PROGNOSIS;
PRURITUS;
REDUCTION;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
VAGINA DISCHARGE;
|
EID: 0036202196
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(02)00011-4 Document Type: Article |
Times cited : (60)
|
References (0)
|